University of Utah biomedical engineering chair and Distinguished Professor David Grainger is one of this year’s recipients of the Daniels Fund Ethics Initiative Leadership in Education Award.
The award honors “faculty and staff across the campus of the University of Utah for their successful efforts to create new ethics-related courses, to integrate new business ethics content into existing courses, to mentor students on ethics initiatives and to help make business ethics a permanent fabric of our business school and other University of Utah academic programs and curricula.” The awards are bestowed by the Daniels Fund Ethics Initiative at the U’s David Eccles School of Business.
“Research integrity and objective communication is so important to how we teach our students, mentor future researchers and represent ourselves to our colleagues and peer citizenry,” said Grainger. “This award is among few that focus on these critical research ethics issues. I am indeed honored with the Daniels Fund recognition for my persistent efforts to produce and disseminate educational materials for research integrity and responsibility.”
Other recipients of this year’s award include:
Sue Sundar — Operations and Information Systems
Rodrigo Noriega — College of Science
Jeffrey Botkin — College of Health Sciences
Paul Hu — Operations Management
Chrisoula Andreou — College of Humanities
Jorge Contreras — College of Law
Teneille Brown — College of Law
Each educator will receive a monetary award, as well as a plaque and medallion at the Spring 2019 David Eccles Awards ceremony, and invitation to the annual Daniels Foundation conference in Colorado in 2019.
“We thank these colleagues for providing wonderful opportunities to students and other education seekers to learn, discuss, debate, compete and grow personally and professionally in many ways,” said Abe Bakhsheshy, director of the Daniels Fund Ethics Initiative at the David Eccles School of Business.
Grainger is a Distinguished Professor and department chair of the biomedical engineering and also professor and former chair of pharmaceutics and pharmaceutical chemistry at the U. His research focuses on improving drug delivery methods, implanted medical device and clinical diagnostics performance, and nanomaterials toxicity.
He has received the 2016 Fulbright Scholar Award (New Zealand), the 2013 Excellence in Surface Science Award (Surfaces in Biomaterials Foundation), the 2007 Clemson Award for Basic Research (Society for Biomaterials), and the 2005 American Pharmaceutical Research and Manufacturer’s Association’s award for “Excellence in Pharmaceutics.”
Grainger consults widely for the biomedical device and pharmaceutical industry and has been a principal in six biotech startups, some that have led to successfully-marketed products.